Literature DB >> 28356374

Concordance between upper and lower airway microbiota in infants with cystic fibrosis.

Sabine M P J Prevaes1, Wouter A A de Steenhuijsen Piters1,2, Karin M de Winter-de Groot1,2, Hettie M Janssens3, Gerdien A Tramper-Stranders1, Mei Ling J N Chu1, Harm A Tiddens3, Mireille van Westreenen4, Cornelis K van der Ent1, Elisabeth A M Sanders1, Debby Bogaert5.   

Abstract

Nasopharyngeal and oropharyngeal samples are commonly used to direct therapy for lower respiratory tract infections in non-expectorating infants with cystic fibrosis (CF).We aimed to investigate the concordance between the bacterial community compositions of 25 sets of nasopharyngeal, oropharyngeal and bronchoalveolar lavage (BAL) samples from 17 infants with CF aged ∼5 months (n=13) and ∼12 months (n=12) using conventional culturing and 16S-rRNA sequencing.Clustering analyses demonstrated that BAL microbiota profiles were in general characterised by a mixture of oral and nasopharyngeal bacteria, including commensals like Streptococcus, Neisseria, Veillonella and Rothia spp. and potential pathogens like Staphylococcus aureus, Haemophilus influenzae and Moraxella spp. Within each individual, however, the degree of concordance differed between microbiota of both upper respiratory tract niches and the corresponding BAL.The inconsistent intra-individual concordance between microbiota of the upper and lower respiratory niches suggests that the lungs of infants with CF may have their own microbiome that seems seeded by, but is not identical to, the upper respiratory tract microbiome.
Copyright ©ERS 2017.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28356374     DOI: 10.1183/13993003.02235-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

1.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Authors:  Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

2.  Differences in the lower airway microbiota of infants with and without cystic fibrosis.

Authors:  Katherine B Frayman; Kristine M Wylie; David S Armstrong; Rosemary Carzino; Stephanie D Davis; Thomas W Ferkol; Keith Grimwood; Gregory A Storch; Sarath C Ranganathan
Journal:  J Cyst Fibros       Date:  2018-12-21       Impact factor: 5.482

3.  Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis.

Authors:  Brett R Loman; Chandra L Shrestha; Rohan Thompson; Judith A Groner; Asuncion Mejias; Kathryn L Ruoff; George A O'Toole; Michael T Bailey; Benjamin T Kopp
Journal:  Pediatr Pulmonol       Date:  2020-04-10

Review 4.  Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New.

Authors:  George A O'Toole
Journal:  J Bacteriol       Date:  2018-01-24       Impact factor: 3.490

5.  Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation.

Authors:  Maartje I Kristensen; Karin M de Winter-de Groot; Gitte Berkers; Mei Ling J N Chu; Kayleigh Arp; Sophie Ghijsen; Harry G M Heijerman; Hubertus G M Arets; Christof J Majoor; Hettie M Janssens; Renske van der Meer; Debby Bogaert; Cornelis K van der Ent
Journal:  J Pers Med       Date:  2021-04-27

6.  Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.

Authors:  Juan de Dios Caballero; Rafael Vida; Marta Cobo; Luis Máiz; Lucrecia Suárez; Javier Galeano; Fernando Baquero; Rafael Cantón; Rosa Del Campo
Journal:  mBio       Date:  2017-09-26       Impact factor: 7.867

7.  The concordance between upper and lower respiratory microbiota in children with Mycoplasma pneumoniae pneumonia.

Authors:  Wenkui Dai; Heping Wang; Qian Zhou; Xin Feng; Zhiwei Lu; Dongfang Li; Zhenyu Yang; Yanhong Liu; Yinhu Li; Gan Xie; Kunling Shen; Yonghong Yang; Yuejie Zheng; Shuaicheng Li
Journal:  Emerg Microbes Infect       Date:  2018-05-23       Impact factor: 7.163

Review 8.  The Microbiome in Cystic Fibrosis Pulmonary Disease.

Authors:  Alice Françoise; Geneviève Héry-Arnaud
Journal:  Genes (Basel)       Date:  2020-05-11       Impact factor: 4.096

Review 9.  Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.

Authors:  Anne M van der Does; Gimano D Amatngalim; Bart Keijser; Pieter S Hiemstra; Remi Villenave
Journal:  Vaccines (Basel)       Date:  2018-07-28

10.  Genetic relatedness of Staphylococcus aureus isolates obtained from cystic fibrosis patients at a tertiary academic hospital in Pretoria, South Africa.

Authors:  T Goolam Mahomed; M M Kock; R Masekela; E Hoosien; M M Ehlers
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.